Article
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
Critical reviews in oncology/hematology - 1 Dec 2017
Vuong Huy Gia, Altibi Ahmed M A, Duong Uyen N P, Ngo Hanh T T, Pham Thong Quang, Chan Aden Ka-Yin, Park Chul-Kee, Fung Kar-Ming, Hassell Lewis
Abstract excerpt
The clinical significance of telomerase reverse transcriptase (TERT) promoter mutation in glioma remains unclear. The aim of our meta-analysis is to investigate the prognostic impact TERT promoter mutation in glioma patients and its interaction with other molecular markers, particularly Isocitrate Dehydrogenase (IDH) mutation from aggregate level data. Relevant articles were searched in four electronic databases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.